News

AllStripes announces $50 million Series B financing

AllStripes expands rare disease research programs to United Kingdom

AllStripes announces collaboration with Taysha Gene Therapies for SURF1-Associated Leigh syndrome program

AllStripes announces partnership with Penn’s Orphan Disease Center

It’s official, RDMD has a new name: AllStripes

RDMD secures $14 million in Series A financing and announces partnership with UCB in rare neurodegenerative disease

The reality of optimising real-world data

Transforming the Rare Disease Landscape with Data

Rare disease data-focused AllStripes raises $50M

AllStripes reels in $50 million to up efficiency of rare disease R&D

AllStripes raises $50 million to support rare disease research

Why this tech company raised $50M to tackle dozens of rare diseases

Digital Health 150: The digital health startups transforming the future of healthcare

100 of the most inspiring people

Abundant funding, sparse data: San Francisco startup backs ‘real world’ model for rare disease drug development

RDMD lands $14M to expand reach of rare disease research platform

RDMD named a 2020 TEDMED hive innovator

Digital Health 150: RDMD is one of the digital health startups redefining the healthcare industry

RDMD co-founders to participate in upcoming rare disease and health technology conferences

10 recent examples of powerful innovation in healthcare

Allogene, Cortexyme & RDMD headline Xconomy’s Dec. 5 Biotech Forum

You acted, the industry responded: we just raised $3 million

The clock is ticking faster for a patient turned medical disruptor

Accelerating NF research through technology

Power to the patients

Hack your DNA

Can hackers save this man’s hearing and eyesight?

If your doctors can’t cure your cancer, maybe you can